Press Releases

September 25, 2017
iCAD Announces Presentation of New Clinical Data on Xoft System for Treatment of Nonmelanoma Skin Cancer and Early-Stage Breast Cancer at ASTRO 2017
Read More

August 30, 2017
iCAD Announces Approval of Xoft® Axxent® Balloon Applicators by China Food & Drug Administration for Treatment of Early-Stage Breast Cancer
Read More

July 27, 2017
Researchers to Present Clinical Data Supporting Use of Xoft System for Endometrial Cancer Treatment at American Association of Physicists in Medicine Annual Meeting & Exhibition
Read More

July 19, 2017
iCAD announces positive study results comparing use of company’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® to Mohs surgery in treatment of early-stage non-melanoma skin cancer
Read More

May 5, 2017
First-Ever European Analysis of Electronic Brachytherapy Using the Xoft System for Endometrial and Cervical Cancer Treatment to be Presented at European Society for Radiotherapy & Oncology Meeting
Read More

May 1, 2017
iCAD Announces First Early-Stage Breast Cancer Patient Treated with Intraoperative Radiation Therapy Using the Xoft System at Monash Cancer Centre, a partnership between Peter MacCallum Cancer Centre and Monash Health in Australia
Read More

April 26, 2017
iCAD to Showcase Breakthrough Early-Stage Breast Cancer Treatment Utilizing the Xoft System at American Society of Breast Surgeons (ASBrS) Annual Meeting
Read More

April 20, 2017
Researchers to Present Updated Clinical Data on Intraoperative Radiation Therapy Using the Xoft System at American Brachytherapy Society (ABS) Annual Meeting
Read More

March 9, 2017
iCAD Announces More Than 3,000 Early-Stage Breast Cancer Patients Treated with Intraoperative Radiation Therapy Using the Xoft System
Read More

March 3, 2017
iCAD Showcases Targeted, Non-Surgical Non-Melanoma Skin Cancer Treatment at AAD 2017
Read More

December 6, 2016
First-Ever Analysis of Intraoperative Radiation Therapy with Xoft System as a Boost Prior to Whole Breast Radiation to be Presented at San Antonio Breast Cancer Symposium
Read More

September 26, 2016
iCAD to Present Positive Clinical Data Supporting Use of Xoft System for Early-Stage Breast Cancer and Nonmelanoma Skin Cancer at ASTRO 2016
Read More

June 28, 2016
First Cervical Cancer Patient Treated in Europe with the Xoft System at Hospital Universitario Miguel Servet in Spain
Read More

March 4, 2016
iCAD Showcases Latest Technology Supporting Use of Xoft System for Non-melanoma Skin Cancer Treatment at AAD 2016
Read More

December 8, 2015
Researchers to Present Updated Data Regarding Intraoperative Radiation Therapy with the Xoft System at San Antonio Breast Cancer Symposium

Read More

November 23, 2015
iCAD Reports Use of Xoft® Axxent® Electronic Brachytherapy System in the Treatment of More than 15,000 Non-Melanoma Skin Cancer Lesions

Read More

November 18, 2015
iCAD’s Xoft System Selected as a Popular Science Magazine “Best of What’s New” Award Winner for 2015
Read More

Sept. 30, 2015
iCAD Launches National Educational Program to Increase Awareness of the Effective Use of Electronic Brachytherapy for the Treatment of Nonmelanoma Skin Cancer
Read More

July 13, 2015
ICAD ANNOUNCES COMMERCIAL AVAILABILITY OF CERVICAL APPLICATOR FOR TREATMENT OF GYNECOLOGICAL CANCERS AT AMERICAN ASSOCIATION OF PHYSICISTS IN MEDICINE MEETING
Read More

May 27, 2015
iCAD, Inc. Withdraws 2015 Financial Guidance Due to General Reimbursement Uncertainty
Read More

May 06, 2015
iCAD, Inc. Announces Information Related To Reimbursement Levels
Read More

May 05, 2015
iCAD Launches Digital Customer Training Platform to Support Professional Education in Use of Xoft System for Treatment of Non-Melanoma Skin Cancer, Early-Stage Breast Cancer and Gynecological Cancers
Read More

April 24, 2015
First Hospital in Spain Adopts Xoft Electronic Brachytherapy System for the Treatment of Early-stage Breast Cancer, Non-melanoma Skin Cancer and Gynecological Cancers
Read More

April 07, 2015
Positive Clinical Data for iCAD’s Xoft System to be Highlighted at American Brachytherapy Society (ABS) Annual Meeting
Read More

March 20, 2015
iCAD to Present Positive Four-year Data on Xoft® Axxent® Electronic Brachytherapy (eBx®) System® for Non-melanoma Skin Cancer (NMSC)
Read More

«« Press Release Archive »»

Quick Links

Public Relations

ARPR, LLC
Erin Bocherer
855.300.8209 ext 120
erin@arpr.com

©2017 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.

Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.